Skip to main content
. 2020 Nov 27;11:602114. doi: 10.3389/fneur.2020.602114

Table 1.

Demographic and clinical characteristics of the COVID-19 patients included in the study.

Characteristics All patients
(n = 94)
Patients with neurological complications
(n = 47)
Patients without neurological complications
(n = 47)
Gender [male, n (%)] 74 (78.7%) 41 (87.2) 33 (70.2)
Age (y/o, mean ± SD) 61.6 ± 11.1 62.4 ± 8.3 60.8 ± 13.3
Weight (kg, mean ± SD) 90.0 ± 13.6 82.9 ± 14.2 80.5 ± 13.0
Height (cm, mean ± SD) 176.0 ± 7.9 171.7 ± 7.5 171.8 ± 8.3
BMI (kg/m2, mean ± SD) 29.9 ± 4.2 28.1 ± 4.2 27.3 ± 4.1
Comorbidities [n, (%)]
Hypertension 49 (52.1) 27 (57.4) 22 (46.8)
Chronic renal disease 5 (5.3) 5 (10.6) 0 (0.0)
Diabetes 14 (14. 9) 6 (12.8) 8 (17.0)
Chronic respiratory disease 0 (0.0) 0 (0.0) 0 (0.0)
Chronic liver disease 3 (3.2) 1 (2.1) 2 (4.3)
Cancer 6 (6.4) 3 (6.4) 3 (6.4)
Cardiac failure 8 (8.5) 5 (10.6) 3 (6.4)
Neurological disease 0 (0.0) 0 (0.0) 0 (0.0)
Hospital length of stay (days, mean ± SD) 28.10 ± 23.00 36.77 ± 25.14 19.43 ± 16.86
ICU length of stay (days, mean ± SD) 21.51 ± 20.14 31.51 ± 22.64 11.51 ± 10.14
ICU outcome [n, (%)]
Alive 61 (64.90) 31 (65.95) 30 (63.83)
Critical 2 (2.10) 2 (4.25) 0 (0.00)
Death 31 (33) 14 (29.78) 17 (36.17)
Days of mechanical ventilation (days, mean ± SD) 20.00 ± 16.33 22.93 ± 19.62 8.85 ± 7.75
Days from symptoms to hospital admission (days, mean ± SD) 3.98 ± 10.11 3.81 ± 7.16 4.14 ± 12.42
Days from symptoms to ICU admission (days, mean ± SD) 10.92 ± 6.84 9.51 ± 6.73 12.30 ± 6.74
Higher D-dimer during ICU stay (ng/ml, mean ± SD) 17.636 ± 26.631 14.067 ± 21.401 17.878 ± 31.310
Higher CRP during ICU stay (mg/L, mean ± SD) 266.25 ± 120.88 232.78 ± 127.49 161.47 ± 102.81
Lower PaO2 during ICU stay (mmHg, mean ± SD) 60 ± 10.92 52.97 ± 7.80 57.96 ± 13.03

n, number; SD, standard deviation; y/o, years old; BMI, body mass index; ICU, intensive care unit; PaO2, partial pressure of oxygen; CRP, C-reactive protein.